Catalyst starts process to offer Firdapse at no cost to LEMS patients in US

By -

Catalyst starts process to offer Firdapse at no cost to LEMS patients in US
US-based Catalyst Pharmaceutical Partners has initiated the process necessary to establish an expanded access program (EAP) to make available its investigational potassium channel inhibitor, Firdapse in the US, to patients diagnosed with Lambert-Eaton Myasthenic Syndrome (LEMS) through their neuromuscular disease specialists.
Currently, Firdapse (amifampridine phosphate or 3,4-DAP phosphate) is in Phase III development and it will be provided at no cost until sometime following approval.
Patient enrollment in the Phase III development is expected to start in the next few months, pending FDA review and approvals.
Catalyst Pharmaceutical Partners CEO Patrick McEnany said, "As part of our ongoing commitment to the LEMS community, we are making Firdapse available to those who would like access to this investigational drug, but are unable to participate in clinical studies or travel to sites where it is available."
University of Alabama at Birmingham professor Emeritus of Neurology Shin Oh said, "In previously published clinical trials, amifampridine has been shown to reduce neuromuscular weakness and symptoms of autonomic dysfunction in LEMS patients while being well tolerated."
In patients with LEMS, the release of acetylcholine is decreased at the neuromuscular junction, resulting in muscle weakness.

Credit link info: http://processandproduction.pharmaceutical-business-review.com/news/catalyst-starts-process-to-offer-firdapse-at-no-cost-to-lems-patients-in-us-240414-4220046Credit for this info link..........

Comments

Post a Comment

Word verification with comments to show us your human and not auto spam junk.

Popular posts from this blog

How-much-will-a-pack-of-joints-cost-the-future-of-mass-market-marijuana?

By -
How-much-will-a-pack-of-joints-cost-the-future-of-mass-market-marijuana? Marijuana is for sale in Colorado and Washington, so it's seemingly only a matter of time before packs of joints are available as well — but how much will a pack run you? After doing some extensive research,  Fast Company 's   Thor Benson came up with around $50. He reached that number by comparing the estimated cost of marijuana production (about $2 to $3 per gram) with common industry margins (rumored to be between 40 percent and 50 percent) and factoring in the economies of scale wielded by large companies like Marlboro. At the very most, an average pack of joints might run you about $120 — the amount Denver-based store Medicine Man asks for a 20-pack of pre-rolled, one-gram joints. Benson even sought input from Jeff Caldwell, a representative from Marlboro's parent company, but Caldwell wouldn't speculate on the potential costs of joint packs. Caldwell said that his company had "no plans t
Read more

Cancer

By -
https://www.google.com/url?rct=j&sa=t&url=https://hillaryhq.com/2018/07/14/sandhill-capital-partners-has-decreased-eaton-plc-com-etn-position-by-6-84-million-dollar-general-dgs-sentiment-is-1-07/&ct=ga&cd=CAEYACoTNTQyMTIyNDcxNjY1MzA3MjMzMTIaNjUzNmMwZDcxNjk0OWJjYzpjb206ZW46VVM&usg=AFQjCNFAPV6SMEcORYOc_faj0MAaKUvO7A
Read more

Myasthenia Gravis vs. Lambert Eaton Syndrome ?

By -
Image
Question: What is the difference between Myasthenia Gravis and Lambert-Eaton syndrome? How do doctors differentiate between the two in diagnosis? Is the treatment similar? Answer: Myasthenia gravis causes muscle weakness that patients usually appreciate becoming significantly worse with activity. Double vision, swallowing and speaking abnormalities, and difficulty walking and using the arms are common symptoms. Lambert-Eaton may produce similar symptoms, but double vision is less common. Muscle aches are more common and patients often have dry mouth. Patients may also have impotence, constipation, impaired sweating, and blurred vision. Myasthenia gravis is caused by antibodies against acetylcholine receptor and compromise the muscle side of the nerve-muscle communication point. Lambert-Eaton syndrome appears to be caused most often by antibodies to calcium channels of the nerve. Lambert-Eaton is often triggered by the development of a lung cancer. An EMG test can differentiate
Read more